{"id":2635,"date":"2021-01-27T23:45:27","date_gmt":"2021-01-27T21:45:27","guid":{"rendered":"http:\/\/interchem.epicstation.com\/development\/"},"modified":"2025-10-27T22:41:39","modified_gmt":"2025-10-27T20:41:39","slug":"development","status":"publish","type":"page","link":"https:\/\/interchem.ua\/en\/development\/","title":{"rendered":"Development & Analytical Services"},"content":{"rendered":"
InterChem SLC<\/strong> embodies a scientific approach to the pharmaceutical business, innovation, and an unparalleled R&D foundation. Within our large-scale manufacturing complex operates a robust R&D division<\/strong>: several in-house advanced laboratories; a long-standing, productive partnership with the O.V. Bogatsky Physico-Chemical Institute of the National Academy of Sciences of Ukraine<\/strong>; and, since 2005, the Research & Technological Laboratory of Finished Dosage Forms (R&D SDF Lab, formerly Formula B LLC)<\/strong> established jointly with the German company Meggle<\/strong>.<\/p>\n InterChem SLC provides high-quality services in pharmaceutical development of active pharmaceutical ingredients (APIs)<\/strong>, solid dosage forms<\/strong>, and API reference standards & impurity reference materials<\/strong>.<\/p>\n The Research & Technological Laboratory of APIs (R&T API Lab)<\/strong> develops methods for the synthesis and purification of APIs<\/strong> not only for in-house production but also under contract. The unit\u2019s capacity enables clients to commission multi-step syntheses (up to 9 stages)<\/strong> of high complexity.<\/p>\n The R&T API Lab develops and industrializes processes for all generic APIs<\/strong> produced by InterChem SLC (including clonidine, proserin, mebicar, clonazepam<\/strong>, and others). In addition, the company\u2019s laboratories have implemented industrial technologies for original medicines<\/strong> such as Amixin\u00ae, Gidazepam\u00ae, and Levana\u00ae (cynazepam)<\/strong>. The laboratory is actively advancing new directions<\/strong>, with several products currently at the pilot-scale manufacturing<\/strong> stage.<\/p>\n At the request of pharmaceutical manufacturers, InterChem SLC has developed purification methodologies<\/strong> for novocaine, camphorsulfonic acid, analgin, dibazol, dopamine<\/strong>, and others, as well as routes of synthesis<\/strong> for several generic substances<\/strong>.<\/p>\nInterChem SLC Technologies<\/h3>\n
Contract Technologies<\/h3>\n